Cargando…
Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment
PURPOSE: To report on the management and effectiveness of treating patients with stage I Neurotrophic Keratitis using an 8-week course of topical recombinant human nerve growth factor (rhNGF, cenegermin). OBSERVATIONS: In this retrospective case series, punctate epithelial erosions (PEE), best corre...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350864/ https://www.ncbi.nlm.nih.gov/pubmed/35938145 http://dx.doi.org/10.1016/j.ajoc.2022.101649 |